Loading…
Daikaffil Chemicals India (BSE 530825)₹40.06−6.27%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Daikaffil Chemicals India reported sales of ₹1.02 Cr and net profit of −₹0.69 Cr. For the year to Mar 2026, sales were ₹13.33 Cr and net profit −₹2.22 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales | 1.46 | 1.96 | 1.02 |
| Expenses | 1.79 | 2.82 | 1.64 |
| Operating Profit | −0.34 | −0.87 | −0.63 |
| OPM % | −22.5% | −43.7% | −60.2% |
| Other Income | 0.00 | 0.01 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.08 | 0.09 | 0.07 |
| Profit before tax | −0.40 | −0.93 | −0.70 |
| Tax % | −7.3% | 0.0% | −1.4% |
| Exceptional items | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.39 | −0.94 | −0.69 |
| EPS (Rs) | −0.64 | −1.56 | −1.14 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 34.34 | 27.35 | 26.38 | 22.77 | 13.33 |
| Expenses | 31.39 | 24.20 | 21.73 | 19.51 | 15.23 |
| Operating Profit | 2.99 | 3.17 | 4.69 | 3.27 | −1.94 |
| OPM % | 8.7% | 11.5% | 17.6% | 14.2% | −14.5% |
| Other Income | −0.15 | 0.55 | 0.55 | 0.85 | 0.04 |
| Interest | 0.25 | 0.13 | 0.06 | 0.04 | 0.00 |
| Depreciation | 0.41 | 0.39 | 1.47 | 0.96 | 0.35 |
| Profit before tax | 2.13 | 3.19 | 3.67 | 3.09 | −2.24 |
| Tax % | 28.1% | 33.7% | 33.5% | 23.6% | −1.8% |
| Exceptional items | −0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 1.55 | 2.12 | 2.46 | 2.38 | −2.22 |
| EPS (Rs) | 2.59 | 3.51 | 4.08 | 3.99 | −3.69 |
| Dividend payout % | 31.1% | 28.6% | 41.9% | 30.2% | 0.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 6.01 | 6.01 | 6.02 | 6.02 | 6.02 |
| Reserves | 5.23 | 6.61 | 18.40 | 19.55 | 0.79 |
| Borrowings | 1.90 | 0.72 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 7.01 | 5.75 | 3.53 | 4.90 | 2.65 |
| Total Liabilities | 20.15 | 19.09 | 27.95 | 30.47 | 9.46 |
| Fixed Assets | 5.38 | 5.36 | 15.18 | 14.72 | 2.08 |
| CWIP | 0.00 | 0.05 | 0.10 | 0.02 | 0.26 |
| Investments | 0.03 | 0.18 | 0.21 | 2.21 | 0.26 |
| Other Assets | 14.74 | 13.50 | 12.46 | 13.52 | 6.86 |
| Inventories | 4.45 | 4.03 | 3.47 | 3.09 | 2.67 |
| Trade receivables | 6.86 | 7.07 | 2.91 | 4.65 | 2.00 |
| Cash & equivalents | 1.70 | 1.30 | 4.70 | 3.70 | 1.29 |
| Total Assets | 20.15 | 19.09 | 27.95 | 30.47 | 9.46 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 1.72 | 0.71 | 5.06 | 2.65 | 0.60 |
| Cash from investing activity | −0.52 | −0.47 | −0.93 | −2.70 | −0.40 |
| Cash from financing activity | −0.60 | −0.59 | −0.73 | −1.24 | 0.00 |
| Net cash flow | 0.59 | −0.32 | 3.38 | −1.27 | 0.19 |
| Capex | 0.52 | 0.40 | 0.92 | 0.43 | 0.40 |
| Free cash flow | 1.25 | 0.29 | 4.10 | 2.22 | 0.19 |
| CFO / OP % | 89.0% | 52.0% | 138.0% | 108.0% | −33.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 72 | 93 | 39 | 73 | 53 |
| Inventory days | 72 | 83 | 83 | 86 | 101 |
| Days payable | 84 | 69 | 33 | 80 | 59 |
| Cash conversion cycle | 57 | 105 | 87 | 77 | 93 |
| Working capital days | 49 | 85 | 78 | 96 | 88 |
| ROCE % | — | 24.7% | 19.7% | 12.5% | — |
For the Jun 2026 quarter, Daikaffil Chemicals India reported sales of ₹1.02 Cr and net profit of −₹0.69 Cr. The operating margin was −60.2%.
Daikaffil Chemicals India's sales for the year to Mar 2026 were ₹13.33 Cr.
Net profit for the year to Mar 2026 was −₹2.22 Cr. Earnings per share over the same trailing period were ₹−3.69.
Daikaffil Chemicals India reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹1.29 Cr.
Cash from operations was ₹0.60 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.19 Cr.